CDK Global, Inc., together with its subsidiaries, provides integrated data and technology solutions to the automotive, heavy truck, recreation, and heavy equipment industries in the United States and internationally. It offers subscription-based software and technology solutions to automotive retailers, as well as to retailers and manufacturers of heavy trucks, construction and agricultural equipment, motorcycles, boats, and other marine and recreational vehicles. The company's flagship Dealer Management System provides software solutions that facilitates the sale of new and used vehicles, consumer financing, repair and maintenance services, and vehicle and parts inventory management. It also provides a portfolio of layered software applications and services to address the needs of automotive retail workflows. In addition, the company offers data management and business intelligence solutions to automotive retailers and original equipment manufacturers through its Neuron intelligent data platform. Further, it offers professional services, custom programming, consulting, implementation, and training solutions, as well as customer support solutions. The company serves approximately 15,000 retail locations. CDK Global, Inc. was incorporated in 2014 and is headquartered in Hoffman Estates, Illinois.
IPO Year:
Exchange: NASDAQ
Website: cdkglobal.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/16/2021 | $48.00 | Overweight → Equal-Weight | Morgan Stanley |
| 8/18/2021 | $62.00 → $56.00 | Overweight | Morgan Stanley |
Sales and Operational Veteran Brings Additional Global Business Experience and Healthcare Technology Expertise to Board Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell" or the "Company"), a leader in transforming the pharmacy care delivery model, today announced that the Board of Directors elected Eileen Voynick to the Board, effective January 5, 2024. Ms. Voynick fills the vacancy resulting from Sara J. White, a Class I director who stepped down from the Company's Board of Directors, effective January 5, 2024. In addition, the Company announced that Vance Moore will not stand for reelection to the Company's Board at Omnicell's 2024 annual meeting of stockholders (the "2024 annual meeting") and e
OLYPHANT, Pa., April 8, 2021 /PRNewswire/ -- AGS Health, a leader in revenue cycle management solutions, today announced the appointment of Eileen Voynick as board chair. "I'm excited to join the AGS Health team at this pivotal time for growth," said Ms. Voynick. "I look forward to working closely with the leadership team in helping develop forward-thinking revenue cycle management strategies to achieve great results for healthcare providers, enabling them to invest further in care delivery," she noted. Eileen Voynick, AGS Health Board Chair With decades of experience in healthcare technology, life sciences and services, Ms. Voynick is an industry leader with a prove
Morgan Stanley downgraded CDK Global from Overweight to Equal-Weight and set a new price target of $48.00
Morgan Stanley reiterated coverage of CDK Global with a rating of Overweight and set a new price target of $56.00 from $62.00 previously
Oppenheimer reiterated coverage of CDK Global with a rating of and set a new price target of $65.00 from $55.00 previously
Wells Fargo & Company reiterated coverage of CDK Global with a rating of Overweight and set a new price target of $65.00 from $60.00 previously